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MHR3 is an ecdysone-inducible transcription factor whose expression in both Manduca sexta epidermis and the Manduca GV1 cell line
is induced by 20-hydroxyecdysone (20E) in vitro. There are four putative ecdysone response elements (EcRE) in the 2.6-kb flanking region
of the MHR3 promoter. The most proximal, EcRE1, is necessary for activation of the promoter by 20E in the GV1 cells because the mutation
of EcRE1 caused the loss of responsiveness to 20E. Previous studies [Mol. Cell. Biol. 19 (1999) 4897] showed that EcR-B1/USP-1 bound
only to EcRE1 and high levels of this complex increased the 20E-induced activation, whereas the presence of high USP-2 prevented this
increased activation. When we expressed EcR-A alone or in combination with USP-1 under the control of Autographa californica
baculovirus promoter (pIE1hr), the activation of the 2.6-kb promoter by 20E was reduced by about 50%. Moreover, when EcR-A was
expressed together with both EcR-B1 and USP-1, it reduced the normal activation caused by EcR-B1 and USP-1 by 50%. Gel mobility shift
assays showed no binding of EcR-A/USP-1 to EcRE1. The presence of EcR-A, however, reduced the binding of EcR-B1/USP-1 by about
50%. These findings suggest that EcR-A competes with EcR-B1 for binding of USP-1, leading to a decline in activity of the promoter. In
addition, E75A, another ecdysone-induced transcription factor, and MHR3 itself suppressed MHR3 promoter activity by binding to the
monomeric response element (MRE2). Therefore, MHR3 can be down-regulated both by itself and by E75A.
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Introduction receptor superfamily (Mangelsdorf et al., 1995; Thummel,The studies of ecdysone-induced ‘‘puffing’’ patterns in
Drosophila melanogaster larvae at the outset of metamor-
phosis led to a model for how ecdysone activates a cascade
of early genes. The early gene products activate late genes in
the cascade and inactivate the early genes (Ashburner et al.,
1974). When 20E binds to the ecdysone receptor (EcR)/
Ultraspiracle (USP) complex, it initiates this transcriptional
ecdysone cascade leading to molting and metamorphosis
(Cherbas and Cherbas, 1996; Riddiford et al., 2001; Thum-
mel and Chory, 2002). Many, but not all, of the early genes
from these puff sites have been shown to be transcription
factors, and many of them are members of the nuclear0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2004.04.028
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In Drosophila, there are three isoforms of EcR (EcR-A,
EcR-B1 and EcR-B2) (Talbot et al., 1993) but only one USP
(Oro et al., 1990; Henrich et al., 1994), whereas the tobacco
hornworm, Manduca sexta, has two EcRs (EcR-B1 and
EcR-A) (Fujiwara et al., 1995; Jindra et al., 1996) and two
USPs (USP-1 and USP-2) (Jindra et al., 1997). In Drosoph-
ila, most imaginal tissues express predominantly EcR-A at
pupariation whereas most larval tissues express EcR-B1
(Talbot et al., 1993). EcR null mutations resulted in embry-
onic lethality, whereas EcR-B1 mutants have reduced via-
bility as larvae but show major lethality at the beginning of
metamorphosis (Bender et al., 1997). This phenotype sug-
gests a dissociation of metamorphic development, with
larval tissues tending to arrest and imaginal tissues pro-
gressing in their development. The USP mutant, usp2, has a
phenotype that is very similar to the EcR-B mutants (Hall
and Thummel, 1998). The lack of USP causes premature
neuronal differentiation in the wing even in the absence of
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unliganded EcR/USP complex also is suppressing early
metamorphic development, at least in imaginal discs. The
presence of 20E removes this inhibition, thus allowing
development to occur (Schubiger and Truman, 2000).
The early gene protein products, such as E74, E75, and
Broad (BR), regulate the initial cascade of responses to
ecdysone in the mid to late 3rd instar larvae (Burtis et al.,
1990; DiBello et al., 1991; Segraves and Hogness, 1990;
Thummel, 1990). DHR3 (Koelle et al., 1992), a homolog of
the retinoid orphan receptor (RORa) in vertebrates (Gigue´re
et al., 1994), is activated later when the ecdysone titer
increases; therefore, it is considered as an early–late gene
(Huet et al., 1995). DHR3 is required for normal embryonic
development of the central nervous system and for hatching
but has little, if any, effect on cuticle formation (Carney et
al., 1997). Yet in the adult, DHR3 is required for the
development of bristles, wings and cuticle, but has no
apparent action in eye or leg development (Lam et al.,
1999). CHR3, a C. elegans homolog of DHR3, is an
essential epidermal factor that is associated with abdominal
epidermal cell function including molting and body size
regulation (Kostrouchova et al., 1998).
Several genes encoding 20E-induced transcription factors
have been cloned in Manduca such as MHR3 (Palli et al.,
1992), a Manduca homolog of DHR3, E75A and E75B
(Segraves and Woldin, 1993; Zhou et al., 1998b), Broad
(BR) (Zhou et al., 1998a), E74A and E74B (Stilwell et al.,
2003), MHR4 (Weller et al., 2001), and hFTZ-F1 (Weller et
al., 2001). During the final larval molt, the changing ecdys-
teroid titer coordinates changes in both the EcR and USP
isoforms as well as in the transcription factor cascades
(Riddiford et al., 1999) along with EcR-B1, EcR-A, USP-1
and USP-2. When the ecdysteroid titer increases, both EcR-
B1 and USP-2 increase and E75A mRNA transiently
appears. Both EcR-B1 and E75A then decline sharply at
the peak ecdysteroid titer when MHR3, EcR-A and E75B
appear (Zhou et al., 1998b). MHR3 appears when the
ecdysone titer peaks (Palli et al., 1992; Langelan et al., 2000).
20E stimulates MHR3 expression in the general abdom-
inal epidermis (Palli et al., 1992), and MHR3 protein
appears in a pattern-specific manner as the 20E titer rises
during the larval molt. The crochet epidermis is more
sensitive to 20E for the expression of MHR3 than the
abdominal epidermis where MHR3 protein is sequentially
expressed by the spiracle, the dorsal, and the trichogen and
tormogen cells (Langelan et al., 2000). In both the Manduca
GV1 cell line and Manduca larval epidermis, 20E induces
MHR3 with similar kinetics (Palli et al., 1992; Lan et al.,
1997). This induction was found to require EcR-B1 and
USP-1, but to be inhibited by USP-2 (Lan et al., 1999).
Here we show that EcR-A, like USP-2, prevents the
activation action of the EcR-B1/USP-1 on the MHR3
promoter. In addition, E75A, which appears shortly before
MHR3 expression in the epidermis, suppresses the MHR3
expression and MHR3 itself suppresses its own gene.Materials and methods
Cell line, animals, and hormone treatment
The Manduca GV1 cell line was maintained with 10%
fetal bovine serum as previously described (Lan et al., 1997).
Larvae of the tobacco hornworm,M. sexta, were reared on an
artificial diet (Bell and Joachim, 1976) at 25.5jC under
12L:12D conditions. Lights-off was designated as 00:00
Arbitrary Zeitgeber Time (AZT) (Pittendrigh, 1965).
The concentration of 20-hydroxyecdysone (20E) (a gift
of Dr. Takeshi Matsumoto) was determined spectrophoto-
metrically (e240 = 12,677 in EtOH). Anisomycin (AMC)
(Sigma, St. Louis, MO) was used to inhibit protein synthesis
at 10 Ag/ml, a concentration that inhibited >99% total
protein synthesis in the cultured epidermis (Hiruma et al.,
1995). The solution was prepared shortly before its addition.
Construction of plasmids
The expression vectors for pIE1hr/EcR-B1, pIE1hr/USP-1,
and pIE1hr/USP-2 using the promoter of the immediate early
gene of the Autographa californica baculovirus were used in
our previous studies (Lan et al., 1999). The cDNAs of E75A
(Zhou et al., 1998b) and MHR3 (Palli et al., 1992) were
ligated into the pIE1hr/PA vector (a gift from Paul D.
Friesen); the pIE1hr/E75Awas a gift from Dr. Que Lan. Both
cDNAs were shown to produce their proteins using the TNT
Coupled Reticulocyte Lysate System (Promega).
To remove the Ah region from the Manduca EcR-A
cDNA, we used a PCR method with the following primers.
5V-TTCGCGGATCCGCCACCATGAACCAACA-
GATCTGT-3V and 5V-CCCATCAGTACTACATCCATT-
TATACTTGAGGCCGGTGATAATTCTTCTCGACC-
TATTTTCCCATTTGG-3V. Amplification using Pfu Turbo
DNA polymerase (Stratagene) occurred with denaturing
temperature of 95jC for 2 min, annealing of 55jC for 1
min, and extensions of 72jC for 1 min. The original EcR-A
cDNA in the CMX-Not plasmid (Jindra et al., 1996) was
used as template. The resulting product was digested with
BamHI and ScaI, and ligated into the BamHI/ScaI digested
template plasmid. The removal of the Ah region was
confirmed by sequencing. The cDNAwithout the Ah region
was ligated to the pIE1hr/PA vector.
Mutation of MHR3 promoter
Tomutate EcRE1, a PCR approach was used, and the PCR
primer sequences are as follows: 5V-CATTCCCCCGGGTA-
GAAAGCACCGGTTGACGCCGGCGCGTC-3V and 5V-
TTTGGGTCCCGGGTAGAAAGC-3V. Amplification was
performed as above using the 1216 MHR3 CAT construct
as template. The PCR product was digested with SmaI and
MluI, and ligated to the SmaI/MluI digested MHR3 construct
to replace the fragment. The mutation was confirmed by
sequencing.
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To produce EcR-B1-specific RNAi, two EcR-B1-specific
regions were amplified. The forward primers were 5V-
ACGAAACTGCAGTTATGGCGAGGAAAAAGTGAA-
3V and 5V-ACGAAACTGCAGATGAGACGCCGCTGGT-
CAAAC-3V, and the reverse primer was 5V-TGTTCCAA-
GCTTGACGACATGGACTCGTTCTC-3V. The two
regions were amplified separately under the same PCR
conditions mentioned above except for 1-min denaturation
when EcR-B1 cDNA (Fujiwara et al., 1995) was used as
template. The products were digested with PstI and HindIII
and they were ligated into the HindIII-digested pIE1hr/PA
vector, so that an EcR-B1-specific region formed double-
stranded RNA when the construct was transfected into the
Manduca cell line.
Transient transfection and CAT assays
All the transfections were performed as previously de-
scribed using Lipofectin reagent (Lan and Riddiford, 1997).
An hsp 70-h-galactosidase plasmid (pXH70ZT) was
cotransfected in all experiments for normalization of the
transfection efficiency. CAT protein assays were done using
CAT ELISA kit (Roche Molecular Biochemicals).
RNA extractions and immunoblots
Total RNA from the cells was isolated using the modified
method of Chomczynski and Sacchi (1987) (Hiruma et al.,
1997). Dot blot hybridizations (5 Ag total RNA as deter-
mined spectrophotometrically per dot) were performed as
described (Hiruma and Riddiford, 1990). The cDNA probes
and the hybridization conditions were as described in Palli
et al. (1992) for MHR3, Zhou et al. (1998b) for E75A, and
Hiruma et al. (1999) for EcR-A, EcR-B1, USP-1, and USP-
2. The hybridized filters were analyzed by the molecular
imager, Bio-Rad Model GS-505.
Cellular proteins were extracted in the lysis buffer
(Roche Molecular Biochemicals) (10 mM, MOPS, 10 mM
NaCl, 1 mM EDTA, 1% Triton X-100, 0.5 mM PMSF, 1 Ag/
ml antipain, pH 6.5). Protein concentration was determined
with the BCA protein assay kit (Pierce), and 12 Ag total
protein were separated by 9% SDS polyacrylamide gel.
Immunoblotting and the detection of protein were per-
formed as described (Hiruma et al., 1999).
Gel mobility shift assays
The oligonucleotides used as probes (EcRE1, 5V-
CGGGGTCAATGAACCGGT-3V; EcRE2, 5V-GAACGTT-
GATTGCGCAAA-3V; EcRE3, 5V-TATCGTTGACAACT-
CATT-3V; EcRE4, 5V-GTAGTGACAATGACCAGCA-3V,
monomeric receptor element 1 [MRE1], 5V-TTTCC-
GGGGTCAACGACC-3V, MRE2, 5V-GCAATTGTAT-
TAAGGTGAAGGTCATTCTCCAGT- 3 V) w e r e
K. Hiruma, L.M. Riddiford / Deve512synthesized by Gibco BRL or Invitrogen. The probes were
labeled as described previously (Hiruma et al., 1995). One
strand of the oligonucleotide was 32P-labeled at the 5V end
with T4 polynucleotide kinase and [g-32P]ATP, 10-fold
molar excess of the cold complementary strand was added,
and the mixture was heated at 95jC for 2 min, followed by a
slow cooling to the room temperature. The double-stranded
labeled probes were purified by Sephadex G-50 columns
(Sambrook et al., 1989). The cold nucleotides used for
competitors were prepared as described in Hiruma et al.
(1995).
The preparations of proteins for the gel mobility shift
assays (GMSA) were as follows. The GV1 cell extracts
constitutively expressing EcR-B1, EcR-A, USP-1, USP-2,
E75A, and MHR3 were prepared as described in Lan et al.
(1999). In vitro-transcribed-translated EcR-B1, EcR-A,
USP-1, and USP-2 were prepared with the TNT Coupled
Reticulocyte Lysate system (Promega).
Five micrograms of cell extract or 2 Al of reticulocyte
lysate for each of the tested translation products in 19 Al of
buffer containing 1 Ag of poly(dI–dC)(dI–dC) (Sigma), 12
mM HEPES (pH 7.9), 60 mM KCl, 65 mM NaCl, 7.5 mM
MgCl2, 6.6 mM EDTA, 1.2 mM DTT, and 12% glycerol
were preincubated on ice for 5–10 min, and then 50 fmol of
labeled probe and competitor DNA were added. The reac-
tion mixture was incubated for 20 min at 0jC. The mixture
was then run on a 4% polyacrylamide gel containing 2.5%
glycerol in 1 TBE (45 mM Tris–borate, 1 mM EDTA),
which had been pre-run for 3–4 h in 1 TBE. The gels
were dried and then analyzed by the Molecular Imager
System, model GS-505 (Bio-Rad).Results
Construction of a translatable EcR-A cDNA
The Manduca EcR-A cDNA (Jindra et al., 1996) could
not produce a transcript that could be translated into protein
despite several modifications including the addition of the
Kozak consensus sequence (Kozak, 1991) before the start
site. Also, rescreening of our existing cDNA libraries
yielded no other cDNA (unpublished). At its 3V end, the
Manduca EcR-A-specific region contains an exon (Ah)
encoding 43 amino acids (Jindra et al., 1996) that is not
found in either Bombyx (Kamimura et al., 1997) or Dro-
sophila (Talbot et al., 1993) EcR-A cDNAs. In Manduca,
about half of the individuals of our colony lack this exon
(Jindra et al., 1996). Therefore, we removed this region by
the method described in Materials and methods.
In vitro transcription/translation assays showed that the
cDNA without the Ah region produced EcR-A protein
(data not shown). This cDNA was ligated into the pIE1hr/
PA plasmid (pIE1hr/EcR-A) and was transfected into GV1
cells. These cells then produced EcR-A protein as detected
by immunoblot analysis with the EcR-common antibody
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A (f70 kDa) was slightly lower than that of EcR-B1
produced by the transfected pIE1hr/EcR-B1 as expected
due to the smaller size of the EcR-A-specific region (Fuji-
wara et al., 1995; Jindra et al., 1996). Fig. 1 also shows that
no EcR-A is detectable in the nontransfected GV1 cells.
Hormonal regulation of EcR, USP, MHR3, and E75A in the
GV1 cells
EcR and USP
When GV1 cells were treated with 2 Ag/ml 20E, mRNAs
of EcR-B1 and USP-2 increased about twofold (Fig. 2). The
EcR-B1 mRNA peaked at 6 h, then declined. USP-2 mRNA
increased initially, then plateaued between 6 and 24 h. EcR-
A and USP-1 mRNA levels showed little significant change
during the 24-h culture period with 20E. The maximal EcR-
B1 level expressed in the GV1 cells was very similar to that
found in the highest amount in epidermis on day 1 wander-
ing (Jindra et al., 1996), but those of EcR-A and USP-1
were about half that in the epidermis, and that of USP-2 was
slightly lower at times of high expression (Jindra et al.,
1996, 1997; Hiruma et al., 1999).
MHR3 and E75A
Neither E75A nor MHR3 mRNA was detected in the
absence of 20E (Fig. 2). The E75A gene was rapidly
activated by 2 Ag/ml 20E. The mRNA was detected 0.5–1
h after exposure to 20E, peaked at 4 h, then declined slowly
(Fig. 2). Yet the peak level of E75A RNA in these GV1 cellsFig. 1. Expression of EcR-A in GV1 cells. The EcR-A cDNA inserted into
the pIE1hr/PA vector (pIE1hr/EcR-A) and pIE1hr/EcR-B1 was transfected
into the GV1 cell line and 15 Ag cell extracts were run on a 9%
polyacrylamide gel, and EcR proteins were detected with EcR-common
antibody, 9B9 (Jindra et al., 1996).was less than 10% of that found in the epidermal cells
during the pupal molt (W2) (Zhou et al., 1998b).
When the cells were cultured with 2 Ag/ml 20E, MHR3
mRNA appeared 2–3 h later, then attained a plateau
between 6 and 12 h exposure to 20E (Fig. 2) as previously
found by Lan et al. (1997). The level of induced mRNAwas
equivalent to that expressed in the epidermis 6 h before head
capsule slippage stage (HCS) during the 4th instar molt
(Langelan et al., 2000). The addition of the protein synthesis
inhibitor, anisomycin (AMC), which prevented > 99%
protein synthesis in the epidermis under our culture con-
ditions (Hiruma et al., 1995), allowed about 50% of the
normal MHR3 mRNA accumulation, indicating that protein
synthesis is required for its full activation as is also found in
the cultured epidermis (Palli et al., 1992).
Roles of EcR-B1, EcR-A, USP-1, and USP-2 on the
regulation of the MHR3 promoter
The 2571 MHR3 promoter contains four putative
EcREs and is activated in transfected GV1 cells 1–3 h after
the addition of 20E with high levels by 6 h (Lan et al.,
1999). Therefore, in this paper, we have used a 6-h culture
regime to study the activation and inhibition of this pro-
moter by various factors. The activity level of the 2571
construct cultured with 2 Ag/ml 20E for 6 h was referred as
100 for all the further experiments.
The 2571 and 1216 constructs
Fig. 3A shows that when the construct was transfected
into the GV1 cells, the 2571 promoter was activated in
response to 20E for 6 h as found by Lan et al. (1999). When
both EcR-B1 and USP-1 were expressed at constitutively
high levels by cotransfecting both pIE1hr/EcR-B1 and
pIE1hr/USP-1 constructs, the activation of the promoter by
20E was about twofold higher. Expression of either EcR-B1
or USP-1 by itself had little effect. These results are consis-
tent with our previous results (Lan et al., 1999). When either
USP-2 or EcR-Awas expressed together with EcR-B1/USP-
1, the increased activation was suppressed (Fig. 3A). The
suppressive activity of USP-2 was stronger than that of EcR-
A. Whenever USP-2 or EcR-A or both were expressed in the
absence of additional EcR-B1, the levels of the promoter
activity declined to below the control (None) level (Fig. 3A).
When EcRE4 and its adjacent region were removed
(1216 construct), the activation of the promoter by 20E
was reduced by about 50% (Fig. 3B), but the expression of
EcR-B1/USP-1 still induced a twofold higher activation.
This result indicates that EcRE4 and its flanking region are
important to enhance the promoter activity. The suppression
of the promoter activity by USP-2 and EcR-A mirrored that
found for the 2571 construct.
The 596 and 515 constructs
Further truncation deleting EcRE3 (596) reduced acti-
vation to about 20%, but the removal of EcRE2 (515) had
Fig. 2. Hormonal regulation of the RNA expressions of EcR, USP, MHR3, and E75A in GV1 cells. The cells were treated with 2 Ag/ml 20E for varying hours,
and then total RNAs were isolated to determine the amount of RNA by dot blot hybridizations. N = 6. The relative abundance of RNAs of EcR-A, EcR-B1,
USP-1, USP-2, MHR3, and E75A were referred to the levels of mRNA in the epidermis as Day 1 Wandering stage (W1) = 170, W1 = 70, Day 0 5th = 180,
HCS = 100, 6 h before HCS = 90 and W2 = 900, respectively.
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rounding regions are also necessary for the enhanced
activation, but EcRE2 is not. Both constructs showed over
twofold increased activation in response to 20E when
increased levels of EcR-B1 and USP-1 were present. Just
as with the longer constructs (2571 and 1216), expres-
sion of EcR-A reduced this activation.
The mutation of EcRE1
Fig. 3C clearly shows that the promoter containing only
EcRE1 responded to 20E and that constitutively high
levels of EcR-B1 and USP-1 enhanced this response.
Lan et al. (1999) showed that EcRE1 was crucial for the
activation of the MHR3 promoter, because the removal of
the 95 bp (nt342 to247; SmaI/BamHI) including EcRE1
completely abolished the promoter activity. When EcRE1,GGGGTCAATGAACC, was mutated to GGGTAGAAAG
CACC in the 1216 construct, the basal activity increased
but there was little response to 20E (Fig. 4). The gel mobility
shift assays showed that both reticulocyte lysate- and GV1-
produced EcR-B1/USP-1 did not bind to this mutated ele-
ment (data not shown), supporting the inactivation.
These results clearly show that EcRE1 is essential for the
activation of the MHR3 promoter by 20E. EcRE4 and
EcRE3 and/or their flanking regions are necessary for full
activation. EcR-B1/USP-1 activates the promoter by bind-
ing to EcRE1 in the presence of 20E, unless EcR-A and/or
USP-2 are present.
Action of EcR-A in the absence of EcR-B1
All the experiments conducted above were performed in
the presence of EcR-B1, as EcR-B1 expression is induced
Fig. 3. Effect of EcR and USP isoforms on activation and inactivation of the MHR3 promoter. The pIE1hr expression vectors for EcR-B1, EcR-A, USP-1, and
USP-2 were transfected with the MHR3 promoter ligated to a CAT cDNA, and the cells were exposed to 2 Ag/ml 20E for 6 h. (A)  2571 bp MHR3 promoter
construct, N = 15–20. (B)  1216 bp, N = 15–20. (C)  596 and  515 bp constructs, N = 10–15. None, only empty pIE1hr plasmid was transfected; B1,
EcR-B1; A, EcR-A; U1, USP-1; U2, USP-2. n, 20E; 5, no hormone.
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Fig. 4. Reduction of 20E-induced promoter activity by the mutation of
EcRE1 in the  1216 promoter. EcRE1, GGGTCAATGAACC, was
mutated to GGGTAGAAAGCACC. N = 7. The cells were cultured as in
Fig. 3. The abbreviations were as in Fig. 3. n, 20E; 5, no hormone.
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To prevent the expression of EcR-B1, we transfected a
construct that expresses both the sense and the antisense
RNA of the EcR-B1-specific region (see Materials and
methods), thus forming double-stranded RNA in the cells.
Transfection of EcR-B1-specific RNAi prevented the nor-
mal increase in EcR-B1 protein upon exposure to 20E for 6
h (Fig. 5A). As our transfection efficiency is about 40%
(Lan and Riddiford, 1997), the overall reduction of EcR-B1
protein level was quite high. Fig. 5B shows that the basalFig. 5. (A) Prevention of EcR-B1 expression by the EcR-B1-specific RNAi tran
EcR-B1-specific region was transfected to the cells for 48 h, then the cells were
specific monoclonal antibody (Jindra et al., 1996) was used. The arrow indicates
construct) by EcR-B1-specific RNAi transfection, and the action of EcR-A and U
for 6 h. The abbreviations were as in Fig. 3. N = 4–6. n, 20E; 5, no hormonactivity of the promoter was increased by the expression of
EcR-B1 RNAi, but promoter activation by 20E was severely
reduced (an activation ratio of 8X to 1.3). Under these
conditions, EcR-A and EcR-A/USP-1 had little effect.
Binding of EcR and USP to the putative EcREs
Gel mobility shift assays (GMSA) showed that an EcR-
B1/USP-1 complex bound to EcRE1, but not to either
EcRE2 or EcRE3, and that USP-2 almost completely
prevented this binding (Lan et al., 1999; data not shown).
They also showed that protein(s) bound to EcRE3 in a
probe-specific fashion, but little protein bound to EcRE2.
When GMSA were performed with EcR-A using GV1
cell extracts, no binding to EcRE1 was detected, irrespective
of the presence or absence of USP-1 or USP-2 (Fig. 6A).
Yet EcR-A reduced the binding of an EcR-B1/USP-1
complex to EcRE1 about 50%, but it never completely
prevented this binding as previously found for USP-2
(Lan et al., 1999). These results are consistent with those
of the functional transfection assays in which USP-2 was a
stronger suppressor than EcR-A (Fig. 3A). In addition, there
was no binding of EcR-A/USP-1, EcR-A/USP-2, or EcR-A
to EcRE2, EcRE3 or EcRE4. Also, the EcR-B1/USP-1
complex did not bind to EcRE4 (data not shown).
When reticulocyte lysate-produced proteins, instead of
cell extracts, were used, both EcR-A/USP-1 and EcR-A/USP-
2 complexes bound to EcRE1 as did the EcR-B1/USP-1
complex (Fig. 6B). Importantly, the addition of a GV1 cell
extract prevented binding of the EcR-A/USP complexes.sfection. The pIE1hr construct that produces sense and antisense RNAs of
treated with 2 Ag/ml 20E for 6 h followed by immunoblot. The EcR-B1-
EcR-B1. (B) Inhibition of the activation of the MHR3 promoter ( 2571
SP-1 on the promoter activity. The cells were cultured with 2 Ag/ml 20E
e.
Fig. 6. Gel mobility shift assays using EcRE1. (A) GV1 cell extracts
expressed denoted factors were used. (B) TNT-coupled reticulocyte lysate
produced proteins were used. The abbreviations were as in Fig. 3. GV1, 5
Ag GV1 cell extract was added.
Fig. 8. Gel mobility shift assays using MRE2 and MRE1. GV1 cell extracts
produced E75A and MHR3 were used as protein source.
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promoter
In the 2571-bp promoter region of MHR3, there are at
least two putative monomeric response elements (MRE1
and MRE2) (Fig. 7) (Harding and Lazar, 1993). One of
them, MRE2, is preceded by an AT-rich region (TAT-
TAAGGTGAAGGTCATTC) that has been shown to be
important for the monomeric binding of nuclear receptors
(Harding and Lazar, 1993). By contrast, MRE1 is not
preceded by these sequences. Both E75A and DHR3, the
Drosophila ortholog of MHR3, in Drosophila bind to the
consensus Ear 1 (A/T-AGGTCA) (Horner et al., 1995).Fig. 7. Suppression of the MHR3 promoter by E75A and MHR3. pIEhhr/E75A an
20E; 5, no hormone.  2571,  1216, and  596 constructs, N = 15;  515 coWhen either E75A or MHR3 was expressed constitutively
at high levels in the GV1 cells, the activation of the 2571
MHR3 promoter construct by 20Ewas reduced by about 50%
(Fig. 7). When the promoter was truncated to remove MRE2,
neither MHR3 nor E75A was able to inhibit the 20E induc-
tion (construct 1216, 596, and 515 in Fig. 7). GMSA
showed that both MHR3 and E75A bound to MRE2, but not
to MRE1 (Fig. 8). Neither E75A nor MHR3 bound to any of
the four EcREs in the promoter region (data not shown).d pIEhhr/MHR3 were transfected and cultured with 2 Ag/ml 20E for 6 h. n,
nstruct, N = 5.
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MHR3 expression in both Manduca epidermis and the
Manduca GV1 cell line is induced by 20E. The patterns of
MHR3 RNA expression are essentially the same in both
cells. Addition of a protein synthesis inhibitor reduced the
MHR3 RNA accumulation by about half in both cell types
(Palli et al., 1992; Fig. 2), indicating that 20E acts directly
on the gene, but some protein is required for its full
activation. Therefore, the GV1 cells provide a good system
in which to study the regulation of the MHR3 promoter by
various 20E-regulated transcription factors.
EcRE1 is the primary EcR/USP binding site
There are four putative ecdysone response elements
(EcRE) in the 2.6-kb flanking region of the MHR3 promot-
er, but only the most proximal EcRE1 apparently is neces-
sary for activation of the promoter by 20E (Lan et al., 1999;
Fig. 6). When this element and its flanking region (95 bp)
was removed (Lan et al., 1999) or when this element was
mutated (Fig. 4), no activation occurred.
Full activation by 20E requires the presence of the
upstream promoter containing both EcRE4 and EcRE3 as
removal of this region caused about an 80% reduction in
activation with 50% of the reduction occurring with the
truncation to1216 bp (Lan et al., 1999; Fig. 3). Removal of
the region containing EcRE2 had no effect. Some cellular
protein(s), but not EcR or USP, bound to EcRE3 (Lan et al.,
1999), but no proteins bound to EcRE4 (data not shown).
The proteins binding to EcRE3, however, are neither E75A
nor MHR3. These results suggest that EcRE3, but not EcRE2
or EcRE4, may be important for full activation as well as
some unknown response element(s) in the upstream region.
Suppression of activation of the MHR3 promoter by EcR-A
Activation of the MHR3 promoter requires EcR-B1
because when EcR-B1 levels were decreased by use of
EcR-B1 RNAi, very little activation occurred (Fig. 5).
Addition of EcR-A could not substitute for EcR-B1 under
these conditions. Nor could EcR-A in the presence of either
USP-1 or USP-2 activate the promoter. These findings are
similar to those of Hu et al. (2003) who found that the
isoform-specific domains of Drosophila EcR-B1 and -B2
could activate the eip71 promoter but that of EcR-A could
not. Using an artificial promoter containing four copies of a
synthetic EcRE (PAL1), Mouillet et al. (2001) found that
both EcR-B isoforms activated whereas activation by EcR-
Awas only about one-third that of EcR-B1. When they used
only the isoform-specific domains fused to a Gal4 DNA-
binding domain, the EcR-A-specific domain showed no
activation and reduced basal promoter activity.
Our gel shift experiments suggest that the inability of
EcR-A to activate the MHR3 promoter in the GV1 cells is
due to its inability to bind to EcRE1. This inability to bind isnot an intrinsic feature of EcR-A as EcR-A produced in
reticulocyte lysates can bind as a heterodimer with either
USP-1 or USP-2 to this EcRE. Addition of cell extract,
however, prevented this binding. We do not know whether
this effect is due to a modification of EcR-A by the extract
or to factors that interact with it and suppress the binding.
Importantly, this effect is specific to EcR-A.
Despite its lack of binding to the ecdysone response
element, EcR-A reduced the binding of EcR-B1/USP-1 to
EcRE1 by about 50% and thereby partially inhibited its
activation of the MHR3 promoter. Because this reduction
cannot be a competition with EcR-B1 for binding, EcR-A
likely competes for binding to USP-1 and thus reduces the
amount of EcR-B1/USP-1 complex available to bind to
EcRE1. Consequently, activation of the promoter by 20E
is less. The same explanation presumably holds for USP-2
competing with USP-1 for binding to EcR-B1. A compar-
ison of the nearly total reduction of binding by high
expression of USP-2 (Lan et al., 1999) versus the partial
reduction by high expression of EcR-A suggests that USP-2
is more effective in competition for EcR-B1 than EcR-A is
for USP-1. The reason for the difference in competitiveness
is unclear. One possibility is the amount produced by the
pIE promoter is different in the two cases. When EcR-Awas
overexpressed in Drosophila wing discs using an engrailed-
Gal 4 driver, both DHR3 and E75B expression was de-
creased (Schubiger et al., 2003). This result was thought to
be due to the competition of EcR-A with EcR-B1 for
binding sites leading to the reduction of activation since
EcR-A had been found to be a poor activator (Mouillet et
al., 2001; Hu et al., 2003), but it could be equally as well
explained by EcR-A competing for USP.
E75A as a repressor of MHR3 and a feedback action of
MHR3
E75A is an ecdysone-inducible transcription factor (Seg-
raves and Hogness, 1990; Zhou et al., 1998b). In the GV1
cells, E75A expression was also induced by 20E, but the
amount induced was extremely low when compared with
expressing tissues such as epidermis (Fig. 2). In Manduca
epidermis, E75A expression occurs shortly before the
MHR3 expression during the last larval molt (Zhou et al.,
1998b; Langelan et al., 2000). Therefore, it may be one of
the 20E-induced proteins involved in regulating MHR3
expression.
Drosophila E75A and DHR3 (a Drosophila homolog of
MHR3) bind to the sequence A/GGGTCA preceded by an
AT-rich region as a monomer (Horner et al., 1995). This
element is a typical binding element for the retinoid orphan
receptor (RORa) in vertebrates (Gigue´re et al., 1994). In the
MHR3 promoter region, there is a consensus monomeric
response element (MRE2) (A/T-AGGTCA) (Harding and
Lazar, 1993; Gigue´re et al., 1994; Horner et al., 1995) near
EcRE4, and both E75A and MHR3 bound to MRE2 (Fig.
8). The expression of E75A suppressed the activation of the
Fig. 9. Summary of the roles of the ecdysone receptor (EcR) and
Ultraspiracle (USP) isoforms, and of the transcription factors, E75A and
MHR3, on the regulation of MHR3 by 20E.
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taining this element abolished this suppressive action (Fig.
7). Therefore, in Manduca epidermis, the presence of E75A
early in the ecdysteroid rise likely prevents the immediate
induction of MHR3 when the ecdysteroid titer increases
beyond its threshold for induction (Fig. 9). Normally, E75A
is present only for a short time (Segraves and Hogness,
1990; Zhou et al., 1998b) so when E75A disappears, MHR3
will be induced. Thus, this interplay among the ecdysteroid-
induced transcription factors as well as the ecdysteroid titer
itself is critical to the cascade of appearance of these
transcription factors.
MHR3 itself also binds to the same MRE and inhibits its
own induction (Figs. 7–9). This negative autoregulatory
action thus accounts for the observation that when Manduca
larval epidermis is exposed to 20E in vitro, MHR3 mRNA
first increases, then plateaus, followed by a decrease (Palli et
al., 1992). The decline was prevented by the presence of a
protein synthesis inhibitor.
A Bombyx homolog of MHR3, BmHR3, is not only
activated by 20E (Eystathioya et al., 2001), but also activates
a synthetic promoter which contains four copies of the
RORa response element. But Bombyx E75A represses this
BmHR3-dependent transactivation of the promoter (Swevers
et al., 2002). This suppression by E75A is due to the
competition with MHR3 at the DNA binding site, and
competition for a coactivator binding site located at the C-
terminus of BmHR3. We do not know the inhibitory mech-
anisms of E75A in our case. Further studies are necessary to
understand how the binding of E75A to MRE2 interacts with
other factors to suppress the MHR3 promoter.
During the last larval molt in Manduca, when the
ecdysteroid titer begins to increase, the EcR-B1 mRNA
increases in the epidermis, and EcR-A and USP-2 mRNAs
are also induced with the high titer (Jindra et al., 1996;
Hiruma et al., 1999). USP-1 mRNA declines in response to
high ecdysone titer in the presence of JH (Hiruma et al.,
1999). These observations in the epidermis do not fit
perfectly to the results in the GV1 cell line, suggesting that
the regulation of MHR3 gene expression in the epidermal
cells may involve other factors that the GV1 cells do not
have. When the ecdysone titer begins increasing, E75A
mRNA increases but declines later in response to the high
ecdysone titer (Zhou et al., 1998b). In contrast, MHR3
mRNA does not increase until the ecdysone titer becomes
high (Langelan et al., 2000) when preliminary immunocy-
tochemical studies with an antibody to the common region
of E75 show that protein levels are low (Nelson and
Riddiford, unpublished). Previous studies with a monoclo-
nal antibody to E75A that showed high levels at this time
(Riddiford et al., 2003) are now thought to be artifactual
because this antibody does not recognize E75A protein
expressed in GV1 cells transfected with pIE1hr/E75A (Nel-
son, Hiruma, and Riddiford, unpublished). Therefore, part
of the timing of MHR3 expression in the epidermis is likely
determined by the early suppressive action of E75A on theMHR3 promoter shown in this study. There appear to be
other factors in this 20E-induced regulation because an
ecdysone-inducible protein(s) is also required for the full
activation of the MHR3 gene (Fig. 9). When both USP-2
and EcR-A increase, these factors compete with the EcR-
B1/USP-1 complex at EcRE1, so that the activation of
MHR3 declines. The switch of USP isoforms during this
stage is important to coordinate the expression of MHR3.
MHR3 itself and the declining ecdysteroid titer also facil-
itate the suppression of MHR3.Acknowledgments
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